Premium
Samara Capital’s pharma platform has received interest from the country’s top drug maker and a homegrown private equity firm, among other suitors, two people familiar with the development told VCCircle. Samara had mandated an investment banker earlier this year to scout buyers. Sun Pharma and ChrysCapital have expressed interest in ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
